Effects on type 2 immunity when specifically targeting the interleukin-13 cytokine with tralokinumab

被引：0
|
作者：
Guttman-Yassky, Emma [1 ,2 ]
Kabashima, Kenji [3 ]
Pavel, Ana [4 ]
Staumont-Salle, Delphine [5 ]
Jiang, Li [6 ]
机构：
[1] Icahn Sch Med Mt Sinai, Dept Dermatol, New York, NY USA
[2] Icahn Sch Med Mt Sinai, Inst Immunol, New York, NY USA
[3] Kyoto Univ, Grad Sch Med, Dept Dermatol, Kyoto, Japan
[4] Icahn Sch Med Mt Sinai, Dept Dermatol, Lab Inflammatory Skin Dis, New York, NY USA
[5] Univ Lille, Univ Hosp Lille, Dept Dermatol, Lille, France
[6] LEO Pharma AS, Madison, NJ USA
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2021年 / 85卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
25854
引用
收藏
页码：AB72 / AB72
页数：1
相关论文
共 50 条
  • [1] Interleukin-13: Targeting an underestimated cytokine in atopic dermatitis
    Bieber, Thomas
    ALLERGY, 2020, 75 (01) : 54 - 62
  • [2] Targeting interleukin-13 with tralokinumab reduces S. aureus abundance in adolescents with atopic dermatitis
    Beck, Lisa A.
    Weidinger, Stephan
    Tauber, Marie
    Saeki, Hidehisa
    Irvine, Alan D.
    Eichenfield, Lawrence
    Werfel, Thomas
    Arlert, Petra
    Kurbasic, Azra
    Ropke, Mads A.
    Paller, Amy
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) : AB92 - AB92
  • [3] Interleukin-13 Inhibitors in the Treatment of Atopic Dermatitis: The Role of Tralokinumab
    Dattola, Annunziata
    Tolone, Martina
    Amore, Emanuele
    Bennardo, Luigi
    Trovato, Federica
    Amato, Simone
    Grieco, Teresa
    Richetta, Antonio Giovanni
    Pellacani, Giovanni
    Skroza, Nevena
    Nistico, Steven Paul
    DERMATOLOGY PRACTICAL & CONCEPTUAL, 2024, 14 (03):
  • [4] Regulation of T helper type 2 cell immunity by interleukin-4 and interleukin-13
    McKenzie, ANJ
    PHARMACOLOGY & THERAPEUTICS, 2000, 88 (02) : 143 - 151
  • [5] Exercising Immunity: Interleukin-13 Flexes Muscle
    Webb, Lauren M.
    Wojno, Elia D. Tait
    IMMUNITY, 2020, 52 (06) : 902 - 904
  • [6] Specifically targeting interleukin-13 with tralokinumab improved sleep in two phase III, randomized, double-blind, placebo-controlled trials in patients with atopic dermatitis
    Silverberg, J. I.
    Barbarot, S.
    Gooderham, M.
    Simon, J. C.
    Simpson, E.
    Kurbasic, A.
    Olsen, C. K.
    Cork, M. J.
    BRITISH JOURNAL OF DERMATOLOGY, 2021, 184 (03) : E64 - E65
  • [7] Targeting a Heterogeneous Tumor: The Promise of the Interleukin-13 Receptor α2
    Bodhinayake, Imithri
    Ottenhausen, Malte
    Boockvar, John A.
    NEUROSURGERY, 2014, 75 (02) : N18 - N19
  • [8] Role of interleukin-13 in innate and adaptive immunity
    Brubaker, JO
    Montaner, LJ
    CELLULAR AND MOLECULAR BIOLOGY, 2001, 47 (04) : 637 - 651
  • [9] Targeting Interleukin-13 with Tralokinumab Attenuates Lung Fibrosis and Epithelial Damage in a Humanized SCID Idiopathic Pulmonary Fibrosis Model
    Murray, Lynne A.
    Zhang, Huilan
    Oak, Sameer R.
    Coelho, Ana Lucia
    Herath, Athula
    Flaherty, Kevin R.
    Lee, Joyce
    Bell, Matt
    Knight, Darryl A.
    Martinez, Fernando J.
    Sleeman, Matthew A.
    Herzog, Erica L.
    Hogaboam, Cory M.
    AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2014, 50 (05) : 985 - 994
  • [10] Effects of interleukin-13 on cytokine secretion by human acute myelogenous leukemia blasts
    Bruserud, O
    LEUKEMIA, 1996, 10 (09) : 1497 - 1503
12345